Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Ulcer D014456 16 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Proteinuria D011507 30 associated lipids
Arteriosclerosis D001161 86 associated lipids
Magnesium Deficiency D008275 9 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Chan PK and Gentry PA Inhibition of bovine platelet function by T-2 toxin, HT-2 toxin, diacetoxyscirpenol and deoxynivalenol. 1984 Food Chem. Toxicol. pmid:6540739
Moufarrij NA et al. Thromboxane synthetase inhibition in acute focal cerebral ischemia in cats. 1984 J. Neurosurg. pmid:6542131
Hock CE and Lefer AM Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock. 1984 Circ. Shock pmid:6542462
Chen LS et al. Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension. 1984 Jpn Heart J pmid:6549401
Ishihara Y et al. [Cigarette smoking and lung metabolism--effect of cigarette smoking on blood levels of 6-keto PGF1 alpha, thromboxane B2 and lipoperoxide in healthy volunteers]. 1984 Nihon Kyobu Shikkan Gakkai Zasshi pmid:6549510
Cooper C et al. Production of prostaglandins and thromboxane by isolated cells from intracranial tumours. 1984 J. Neurol. Neurosurg. Psychiatr. pmid:6330309
Watanabe J et al. Effect of vitamin E on platelet aggregation in diabetes mellitus. 1984 Thromb. Haemost. pmid:6495252
Du JT et al. Sex differences in arachidonate cyclo-oxygenase products in elicited rat peritoneal macrophages. 1984 Biochim. Biophys. Acta pmid:6428458
Cuthbert AW et al. Mediators of the secretory response to kinins. 1984 Br. J. Pharmacol. pmid:6331559
Mackey WC et al. Aspirin decreases platelet uptake on Dacron vascular grafts in baboons. 1984 Ann. Surg. pmid:6233945
DiSesa VJ et al. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization. 1984 Ann. Thorac. Surg. pmid:6388516
Takeda H et al. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation]. 1984 Kyobu Geka pmid:6389949
Jackson EK et al. Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485. 1984 Life Sci. pmid:6330486
Huang HC Release of slow reacting substance from the guinea-pig lung by phospholipases A2 of Vipera russelli snake venom. 1984 Toxicon pmid:6206608
Brunner D et al. Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus. 1984 Clin Ther pmid:6206948
Gragnoli G et al. [Effects of ticlopidine on the plasma levels of beta-thromboglobulin and thromboxane B2 in types 1 and 2 diabetics]. 1984 Minerva Med. pmid:6207465
Lewis GP and Smith JR Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo. 1984 Prostaglandins pmid:6435186
MacDermot J et al. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. 1984 Prostaglandins pmid:6326199
Kelton JG et al. A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation. 1984 Thromb. Res. pmid:6740573
Steel LK et al. In vitro prostaglandin release from guinea pig parenchymal lung tissues is not stimulated by thymic peptides. 1984 Int. J. Immunopharmacol. pmid:6427124
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Takeda H et al. [Alternations in coagulation and fibrinolysis associated with extracorporeal circulation--the role of vasoactive prostanoids]. 1984 Rinsho Kyobu Geka pmid:6395300
Tada M et al. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery. 1984 J. Mol. Cell. Cardiol. pmid:6398370
Ylikorkala O Prostanoids in gynaecology. 1984 Ann. Clin. Res. pmid:6398666
Jouve R et al. Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy. 1984 Am. Heart J. pmid:6581715
Grignani G et al. Activation of platelet prostaglandin biosynthesis pathway during neoplastic cell-induced platelet aggregation. 1984 Thromb. Res. pmid:6729776
Marks JG et al. Contact urticaria and airway obstruction from carbonless copy paper. 1984 Aug 24-31 JAMA pmid:6235381
MacNab MW et al. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man. 1984 Feb-Mar J Clin Pharmacol pmid:6371062
Buchanan MR and Hirsh J Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. 1984 Jul-Aug Arteriosclerosis pmid:6380468
Paajanen H et al. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media. 1984 Jul-Aug Invest Radiol pmid:6434489
De Caterina R et al. Thromboxane-B2 generation during ex-vivo platelet aggregation. 1984 Jul-Sep J. Nucl. Med. Allied Sci. pmid:6530623
Egg D Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. 1984 Mar-Apr Z Rheumatol pmid:6730731
Tanabe M et al. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202970
Laustiola K et al. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202971
Sturm M et al. The measurement of plasma thromboxane B2 and the effect of smoking. 1984 Nov-Dec Clin. Exp. Pharmacol. Physiol. pmid:6536421
Menitove JE et al. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. 1984 Nov-Dec Transfusion pmid:6390814
Fisher M et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. 1984 Sep-Oct Stroke pmid:6474531
Uderman HD et al. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat. 1984 Sep-Oct J. Cardiovasc. Pharmacol. pmid:6209508
Ahlsten G et al. Aggregation of and thromboxane B2 synthesis in platelets from newborn infants of smoking and non-smoking mothers. 1985 Prostaglandins Leukot Med pmid:3863152
Rosenkranz B and Frölich JC Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid. 1985 Prostaglandins Leukot Med pmid:3864170
Safai-Kutti S et al. Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients. 1985 Eur. Heart J. pmid:2412820
Demling RH et al. Early lung dysfunction after major burns: role of edema and vasoactive mediators. 1985 J Trauma pmid:2413227
Myśliwiec M et al. Plasma thromboxane B2 in haemodialysed patients. 1985 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2414174
Luzzatto G et al. PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders. 1985 Scand J Haematol pmid:2414843
Papanicolaou N et al. Selective inhibition of renal thromboxane biosynthesis increased sodium excretion rate in normal and saline-loaded rats. 1985 Clin. Sci. pmid:3880524
Bakhle YS et al. Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. 1985 Br. J. Pharmacol. pmid:2996675
Bakhle YS and Grantham CJ Selective effect of pulmonary oedema on prostaglandin E2 pharmacokinetics in rat lung. 1985 Biochem. Pharmacol. pmid:3935117
Hugli TE and Marceau F Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips. 1985 Br. J. Pharmacol. pmid:3921089
Bowers GJ et al. Prostanoid production by lipopolysaccharide-stimulated Kupffer cells. 1985 J. Surg. Res. pmid:3887037
Kiyomiya K and Oh-ishi S Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. 1985 Jpn. J. Pharmacol. pmid:3936958
Panse M et al. An improved malondialdehyde assay for estimation of thromboxane synthase activity in washed human blood platelets. 1985 Prostaglandins pmid:3937179
Yamaguchi M and Mori N 6-Keto prostaglandin F1 alpha, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period. 1985 Am. J. Obstet. Gynecol. pmid:3838119
Patrono C et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. 1985 J. Clin. Invest. pmid:3900132
O'Keefe EH et al. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro. 1985 Prostaglandins pmid:3925501
Schmitz JM et al. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. 1985 Circ. Res. pmid:3926340
Gorczynska E et al. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro]. 1985 Wiad. Lek. pmid:3933184
Shayevitz JR et al. Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect. 1985 Anesthesiology pmid:3933385
Patrono C et al. Clinical pharmacology of platelet cyclooxygenase inhibition. 1985 Circulation pmid:3933848
Gee MH et al. Eicosanoids, leukocytes and lung injury. 1985 Prog. Clin. Biol. Res. pmid:3934681
Leslie JB and Watkins WD Eicosanoids in the central nervous system. 1985 J. Neurosurg. pmid:2997413
Darius H et al. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. 1985 J. Pharmacol. Exp. Ther. pmid:2997428
Zavagli G et al. Platelet aggregation and evaluation of the ratio thromboxane B2/6-keto-prostaglandin F1 alpha in the plasma of patients on long term cimetidine treatment. 1985 Prostaglandins Leukot Med pmid:2997804
Shono F et al. A solid-phase enzyme immunoassay of thromboxane B2. 1985 J. Biochem. pmid:3935648
Sinzinger H Double blind study of the influence of co-dergocrine on platelet parameters in healthy volunteers. 1985 Eur. J. Clin. Pharmacol. pmid:2998802
Greer IA et al. Platelet activation in allergic asthma. 1985 Thromb. Haemost. pmid:2931855
Mikhailidis DP et al. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease. 1985 Eur. J. Clin. Invest. pmid:3938401
McGowan HM et al. The effect of dietary alteration of prostaglandin synthesis on blood pressure and the reversal of hypertension in the one-kidney, one-clip rat. 1985 Prostaglandins pmid:3859891
Klotman PE et al. Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats. 1985 Kidney Int. pmid:2422431
Vesterqvist O et al. In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. 1985 Thromb. Res. pmid:3992528
von Schacky C et al. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. 1985 J. Clin. Invest. pmid:2997286
Wirthumer-Hoche C and Sinzinger H [Protein binding of thromboxane--one of the sources of error in thromboxane determination]. 1985 Wien. Klin. Wochenschr. pmid:3993037
Croft KD et al. Onset of changes in phospholipid fatty acid composition and prostaglandin synthesis following dietary manipulation with n-6 and n-3 fatty acids in the rat. 1985 Biochim. Biophys. Acta pmid:3995069
Eldor A et al. Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction. 1985 Blood pmid:3995180
Pedrinelli R et al. The influence of selective and nonselective prostaglandin inhibition on renin. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159197
Ezra D et al. Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159202
Gensini GF et al. Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159209
De Caterina R et al. Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159210
Trimarco B et al. Indomethacin blunts the late phase of nitroglycerin-induced coronary vasodilatation in dogs. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159220
Zipser RD Effects of selective inhibition of thromboxane synthesis on renal function in humans. 1985 Am. J. Physiol. pmid:3839111
Fink MP et al. Low-dose dopamine preserves renal blood flow in endotoxin shocked dogs treated with ibuprofen. 1985 J. Surg. Res. pmid:3839278
Bornman MS et al. Elevated thromboxane B2 levels during erection. 1985 S. Afr. Med. J. pmid:3839322
Galli C et al. Modification of brain vascular eicosanoids after pharmacological treatment and ischemia in the rat: drugs and brain vascular eicosanoids. 1985 Cephalalgia pmid:3839438
Casey LC et al. The role of thromboxane in primate endotoxin shock. 1985 J. Surg. Res. pmid:3839548
Jindal SK et al. Regulation of increase in anastomotic blood flow following pulmonary arterial occlusion. 1985 J. Appl. Physiol. pmid:3839787
Morris HG et al. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. 1985 Ther Drug Monit pmid:3866409
DiMinno G et al. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. 1985 Blood pmid:2981130
Ment LR et al. Beagle puppy model of perinatal cerebral infarction. Acute changes in regional cerebral prostaglandins during hemorrhagic hypotension. 1985 J. Neurosurg. pmid:4056903
Palmer RM and Salmon JA Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis. 1985 Biochem. Pharmacol. pmid:2986647
Katoh K et al. [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor]. 1985 Masui pmid:4057547
Lynch TJ et al. Carbon tetrachloride-induced eicosanoid synthesis and enzyme release from rat peritoneal leucocytes. 1985 Biochem. Pharmacol. pmid:2986650
Jackson EK Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery. 1985 J. Clin. Invest. pmid:4077980
Armstrong RA et al. Effect of the thromboxane receptor antagonist EP 092 on endotoxin shock in the sheep. 1985 Prostaglandins pmid:2989977
De Caterina R et al. Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction. 1985 Thromb. Haemost. pmid:4082090
Kääpä P Immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in neonatal hyperbilirubinemia. 1985 Prostaglandins Leukot Med pmid:3856285
Delvos U et al. Direct radioimmunological measurement of thromboxane B2 in plasma. 1985 Thromb. Res. pmid:4082109
Semrad SD et al. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. 1985 Am. J. Vet. Res. pmid:4083579
Gay SW and Kosher RA Prostaglandin synthesis during the course of limb cartilage differentiation in vitro. 1985 J Embryol Exp Morphol pmid:3867724
Elliott GR et al. Changes in resident rat peritoneal macrophage eicosanoid release, induced by altering the buffer K+/Na+ ratio, are Ca2+ dependent. 1985 Biochim. Biophys. Acta pmid:3933563
Zijlstra FJ and Vincent JE Leukotriene D4 and phospholipase A2 release thromboxane A2 of different origin in the guinea pig lung parenchymal strip. 1985 Prostaglandins Leukot Med pmid:3857642
Hutchison AA et al. Plasma 6-keto prostaglandin F1 alpha and thromboxane B2 in sick preterm neonates. 1985 Prostaglandins Leukot Med pmid:3859877